National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022 (No. 7) (Cth)

PB 68 of 2022

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022
(No. 7)

National Health Act 1953

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated               28 July             2022

NIKOLAI TSYGANOV

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Contents

1......... Name............................................................................................................................... 1

2......... Commencement............................................................................................................... 1

3......... Authority......................................................................................................................... 1

4......... Schedules......................................................................................................................... 1

Schedule 1—Amendments  2

National Health (Pharmaceutical benefits—early supply) Instrument 2015
(PB 120 of 2015).   2

1. Name

(1)This instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022 (No. 7).

(2)This Instrument may also be cited as PB 68 of 2022.

1. Commencement

(1)Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	1 August 2022	1 August 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

1. Authority

This instrument is made under subsection 84AAA(2) of the National Health Act 1953.

4        Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

1. Schedule 1, after entry for Dipyridamole with aspirin

insert:

Diroximel fumarate Capsule (enteric) 231 mg 20 120 5

1. Schedule 1, entry for Sitagliptin

substitute:

Sitagliptin	Tablet 25 mg	20	28	5
Tablet 50 mg	20	28	5
Tablet 100 mg	20	28	5

1. Schedule 1, entry for Sitagliptin with metformin

substitute:

Sitagliptin with metformin	Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride	20	56	5
Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride	20	56	5
Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride	20	56	5
Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride	20	56	5
Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride	20	28	5